Skip to content
10-K

Annual Report

UNITED THERAPEUTICS Corp UTHR

0001082554-25-000005

← back to feed
Filed
Feb 26, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 44.91M sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $1.21B
Current Liabilities FY 2024 · Dec 31, 2023 $804.4M
Total Liabilities FY 2024 · Dec 31, 2023 $1.18B
Current Assets FY 2024 · Dec 31, 2023 $3.55B
Total Assets FY 2024 · Dec 31, 2023 $7.17B
Shares Diluted FY 2024 · Dec 31, 2022 48.5M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $0
Capex FY 2024 · Dec 31, 2022 $138.8M
Operating Cash Flow FY 2024 · Dec 31, 2022 $802.5M
Eps Diluted FY 2024 · Dec 31, 2022 $15.00
Eps Basic FY 2024 · Dec 31, 2022 $15.98
Sga Expense FY 2024 · Dec 31, 2022 $482.1M
Rd Expense FY 2024 · Dec 31, 2022 $322.9M
Net Income FY 2024 · Dec 31, 2022 $727.3M
Operating Income FY 2024 · Dec 31, 2022 $979.7M
Gross Profit FY 2024 · Dec 31, 2022 $1.78B
Cost Of Revenue FY 2024 · Dec 31, 2022 $151.6M
Revenue FY 2024 · Dec 31, 2022 $1.94B
Stockholders Equity FY 2024 · Dec 31, 2021 $3.96B